Cardinal Health’s stock falls after company says contract with OptumRx will not be renewed after June

Drug distributor backs fiscal 2024 profit guidance despite end of contract that generated 16% of its revenue last year.

Previous post Cruise operator Viking to valued at up to $10.7 billion after IPO terms set
Next post Health, caregiving and estate planning: how to talk about tough topics with aging parents